<p><strong>Posology</strong>: Meningococcal Conjugate Vaccine should be used in accordance with available official recommendations. Primary immunisation:</p>

<ul>
	<li><strong>Infants from 6 weeks to less than 6 months of age</strong>: two doses, each of 0.5 ml, should be administered with an interval of 2 months between doses.</li>
	<li><strong>Infants from 6 months of age, children, adolescents and adults</strong>: a single 0.5 mL doseshould be administered.</li>
	<li>An additional primary dose of Meningococcal Conjugate Vaccine may be considered appropriate for some individuals.</li>
</ul>

<p><strong>Booster doses</strong>: After completion of the primary immunisation course in infants 6 weeks to less than 12 months of age, a booster dose should be given at 12 months of age with an interval of at least 2 months after the last Meningococcal Conjugate vaccination. In previously vaccinated individuals 12 months of age and older, Meningococcal Conjugate Vaccine may be given as a booster dose if they have received primary vaccination with a conjugated or plain polysaccharide meningococcal vaccine.</p>

<p>&nbsp;</p>

<p><strong>Administration</strong></p>

<p>Immunisation should be carried out by intramuscular injection only. In infants, the recommended injection site is the anterolateral aspect of the thigh. In individuals from 1 year of age, the recommended injection site is the anterolateral aspect of the thigh or the deltoid muscle. For instructions on reconstitution of the medicinal product before administration.</p>